Fundraising Fox
Myricx Bio
London, GB · 38 employees on LinkedIn · 5 known investors
Find your way into Myricx Bio
Sign up to see every warm intro you have to Myricx Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Myricx Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment. The company focuses on discovering novel payloads to address unmet oncology needs.
Investors · 5
How we know: Brandon Capital's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: Brandon Capital Partners's portfolio page · Not right? Tell us
How we know: Novo Holdings's portfolio page · funding news · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJul 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
London's Myricx Bio lands up to $1.5B Novartis exit after raising just $121M — TFNtechfundingnews.com · Jul 2026
Imperial cancer therapy spinout Myricx Bio agrees to be acquired by Novartis | Imperial News | Imperial College Londonimperial.ac.uk · Jul 2026Frequently asked questions
- What does Myricx Bio do?
- Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment. The company focuses on discovering novel payloads to address unmet oncology needs.
- Who are Myricx Bio's investors?
- Myricx Bio's investors include Brandon Capital, Brandon Capital Partners, Novo Holdings, Sofinnova Partners, Abingworth.
- Where is Myricx Bio headquartered?
- Myricx Bio is headquartered in London, GB.